ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

LNSR vs SKIN // EV/EBITDA & P/E VALUATION

LENSAR Inc. (NASDAQ) VS. SkinHealth Systems Inc. (Class A) (NASDAQ) • 15-METRIC TALLY: LNSR 3 — SKIN 5
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LNSR VS. SKIN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC LNSR SKIN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 39.40% 65.30% -25.90 SKIN /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -26.90% -8.10 SKIN /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -20.33% — — TIE /fcf-yield <GO>
Operating Margin -47.60% -6.90% -40.70 SKIN /operating-margins <GO>
Net Profit Margin -60.00% -3.20% -56.80 SKIN /net-margins <GO>
Revenue Growth (YoY) 12.40% -10.00% +22.40 LNSR /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 0.20 0.00 TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 6/9 -2.00 SKIN /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 51.5 35.8 +15.66 LNSR /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $73.3M $66.0M $7.3M LNSR /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR LNSR REV SKIN REV LNSR GROSS % SKIN GROSS % LNSR FCF SKIN FCF
FY 2025 $51.7M $300.8M 39.4% 65.3% -$14.9M $37.2M
FY 2024 $46.0M $334.3M 39.9% 54.5% -$2.4M $15.4M
FY 2023 $35.7M $398.0M — — -$9.7M $21.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LNSR // BETA —
SKIN // BETA —